Oncologist. 2020 Nov 11. doi: 10.1002/onco.13590. Online ahead of print.
Lung cancer is the leading cause of cancer death in both males and females in the US and worldwide. Due to advances in prevention, screening/early detection and therapy. Lung cancer mortality rates are decreasing and survival rates are increasing. These innovations are basic on scientific discoveries in imaging, diagnostics, genomics, molecular therapy and immunotherapy. Outcomes have improved in all histologies and stages. This review provides information on the clinical implications of these
innovations that are practical for the practicing physicians, especially oncologists of all specialities who diagnose and treat lung cancer patients.